Vaccination and Infection

Angie Szumlinski Studies

In a study published in JAMA Network, “regularly screened health care workers who had received 2 doses of the BNT162b2 messenger RNA vaccine were associated with significantly lower incidence rates for both symptomatic and asymptomatic infection. The association between vaccination status and symptomatic SARS-CoV-2 infection is similar to the 95% efficacy reported in the phase 3 randomized clinical trial. Asymptomatic …

Third Dose of BNT161b2

Angie Szumlinski News

“The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the …

Interim Public Health Recommendations for Fully Vaccinated People

Angie Szumlinski Featured

This is the first set of public health recommendations for fully vaccinated people. This guidance will be updated and expanded based on the level of community spread of SARS-CoV-2, the proportion of the population that is fully vaccinated, and the rapidly evolving science on COVID-19 vaccines. For the purposes of this guidance, people are considered fully vaccinated for COVID-19 ≥2 …

Nursing Home Vaccination Status Data

Angie Szumlinski Announcements, Featured

New data from Omnicare, a CVS Health company, regarding nursing home vaccination status: Of the nearly 7,822 skilled nursing facilities that have partnered with CVS Pharmacy, all have received their first round of the COVID-19 vaccine, with 81% of second doses already completed. In addition, of the 37,58 assisted living and other long-term care facilities partnered with CVS Pharmacy, 77% …

New President – New Plan

Angie Szumlinski Announcements, News

President Joseph R. Biden has unveiled a plan to jump-start the nation’s faltering COVID-19 vaccine effort that will include establishing mass vaccination sites and mobile vaccine clinics around the nation. The plan calls for a $20 billion investment in a national vaccination program. According to the CDC, 31 million COVID-19 doses have been distributed and 12.2 million have been administered …

Vaccines – The Continuing Saga!

Angie Szumlinski Health, News

Federal health officials in recent days have urged broadening vaccine eligibility to tens of millions of Americans to speed the national inoculation program rollout. Meanwhile, seniors at some long-term care facilities, who account for about 1% of the U.S. population but 40% of COVID-19 deaths and were supposed to be at the front of the line, continue to wait. State …

Post-Vax Symptoms or COVID-19

Angie Szumlinski Health, News

Now that vaccines are being administered around the country, we need to be alert to signs and symptoms post-vaccination. Per the CDC, distinguishing between systemic signs of COVID-19 vaccination symptoms of coronavirus infection will depend on many factors. Clinical judgment will be critical in determining COVID-19 symptoms versus post-vaccination symptoms, beginning with whether the healthcare provider had “unprotected exposure to …

Mutations and Vaccines

Angie Szumlinski Health, News

As scientists are trying to track the spread of a new, more infectious coronavirus variant, it has been identified that the mutation identified in South Africa and Brazil, changes a part of the virus that your immune system’s antibodies get trained to recognize after you’ve been infected or vaccinated. What the lab studies have shown is that the antibodies we …

Evaluating SARS-CoV-2 Vaccines

Angie Szumlinski Announcements, News

The U.S. Food and Drug Administration (FDA) has granted emergency use authorizations (EUAs) for 2 vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), one developed jointly by Pfizer and BioNTech and the other by Moderna. According to company press releases and data made available by the FDA, both vaccines have shown approximately 95% efficacy in preventing symptomatic COVID-19 infections …

Lead By Example – Vaccinate!

Angie Szumlinski Health, Studies

A single state survey was conducted in the state of Indiana to determine the willingness of long-term care staff to receive a COVID-19 vaccine. Staff characteristics including age, gender, race, ethnicity, role in the facility, experience in long-term care, and geographic location of the facility were self-reported along with prior infection and willingness to receive an approved vaccine as soon …